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Abstract Although melatonin is mainly produced by the
pineal gland, an increasing number of extra-pineal sites of
melatonin synthesis have been described. We previously
demonstrated the existence of bidirectional communication
between the pineal gland and the immune system that drives
a switch in melatonin production from the pineal gland to
peripheral organs during the mounting of an innate immune
response. In the present study, we show that acute neuro-
inflammation induced by lipopolysaccharide (LPS) injected
directly into the lateral ventricles of adult rats reduces the
nocturnal peak of melatonin in the plasma and induces its
synthesis in the cerebellum, though not in the cortex or
hippocampus. This increase in cerebellar melatonin content
requires the activation of nuclear factor kappa B (NF-jB),
which positively regulates the expression of the key enzyme
for melatonin synthesis, arylalkylamine N-acetyltransferase
(AA-NAT). Interestingly, LPS treatment led to neuronal
death in the hippocampus and cortex, but not in the cere-
bellum. This privileged protection of cerebellar cells was
abrogated when G-protein-coupled melatonin receptors
were blocked by the melatonin antagonist luzindole, sug-
gesting that the local production of melatonin protects
cerebellar neurons from LPS toxicity. This is the first
demonstration of a switch between pineal and extra-pineal
melatonin production in the central nervous system fol-
lowing a neuroinflammatory response. These results have
direct implications concerning the differential susceptibility
of specific brain areas to neuronal death.
Keywords Pineal gland  Arylalkylamine
N-acetyltransferase (AA-NAT)  Immune-pineal axis 
Neuroinflammation  Melatonin receptors  Nuclear factor
kappa B (NF-jB)
Introduction
The innate immune response is a stereotyped process that
enables an organism to overcome adverse conditions. The
pro-inflammatory phase of the innate immune response is
followed by an adaptive reparative phase in which the
production of anti-inflammatory agents balances poten-
tially harmful substances. The resolution phase restores
homeostatic conditions and tissue function (McCall et al.
2011). In the central nervous system (CNS), the pro-
inflammatory phase must be highly regulated to prevent
conditions that favor neuronal death and disease (Schmidt
et al. 2005; Sastre et al. 2006; Qian et al. 2010; Tansey and
Goldberg 2010).
Melatonin, the product of the acetylation and methyla-
tion of serotonin, is synthesized by the pineal gland in
response to signals from the central biological clock, which
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is, in turn, regulated by the environmental light–dark cycle.
This hormone translates the dark phase to the organism,
synchronizing circadian (Hardeland et al. 2012) and sea-
sonal rhythms (Barrett and Bolborea 2012). Melatonin also
plays a role in the defense of the organisms (Tan et al.
2010a). Extra-pineal melatonin synthesis occurs in several
organs, including the retina (Gern and Ralph 1979; Tosini
and Menaker 1996), the gastrointestinal tract (Raikhlin
et al. 1975; Bubenik 2001), immune competent cells
(Finocchiaro et al. 1991; Carrillo-Vico et al. 2004; Martins
et al. 2004; Pontes et al. 2006) and astrocytes in culture
(Liu et al. 2007b). The paracrine action of extra-pineal
melatonin is important for the organization of immune
responses (Carrillo-Vico et al. 2013).
Recently, the molecular basis for the bidirectional com-
munication between the immune system and the pineal
gland was extensively reviewed (Markus and Ferreira 2011;
Markus et al. 2013). The activation of the transcription
factor nuclear factor kappa B (NF-jB) results in specific
effects that depend on the cellular milieu. In the pineal gland,
NF-jB activation suppresses the expression of the enzyme
arylalkylamine N-acetyltransferase (AA-NAT), which
converts serotonin to the melatonin precursor N-acetylse-
rotonin (NAS) (Fernandes et al. 2006; Markus et al. 2007;
Cecon et al. 2010; Da Silveira et al. 2010; Carvalho-Sousa
et al. 2011; Fernandes and Markus 2011; Da Silveira et al.
2012). Conversely, in bone marrow monocytes, colostrum
defense cells, macrophages and lymphocytes, NF-jB acti-
vation induces the synthesis of melatonin (Conti et al. 2000;
Carrillo-Vico et al. 2004; Pontes et al. 2006; Muxel et al.
2012). These differential effects depend on the cell envi-
ronment and the subtype of dimer that is translocated to the
nucleus (Muxel et al. 2012; Pires-Lapa et al. 2013). Because
the nuclear translocation of NF-jB is triggered by toll-like
receptors (TLRs) or receptors for pro-inflammatory cyto-
kines, in both pinealocytes and immune competent cells, this
transcriptional pathway is considered the basis for the switch
of melatonin production from the pineal gland to immune
competent cells (Markus et al. 2007, 2013).
Understanding the regulation and dynamics of melato-
nin synthesis in physiological and pathophysiological
conditions is essential because of the wide range of bene-
ficial actions of melatonin, especially those related to
neuroprotection (Wang 2009; Cardinali et al. 2010; Cecon
and Markus 2011; Srinivasan et al. 2011). For instance,
dampened melatonin rhythms have been described in sev-
eral neurological disorders, including Alzheimer’s disease,
autism, schizophrenia and multiple sclerosis (Hardeland
2012). This dampening suggests pineal dysfunction, most
likely related to neuroinflammation, which might favor
disease development.
Although astrocytes and microglia were previously
demonstrated to express both enzymes required for
melatonin biosynthesis (Uz et al. 2002; Jimenez-Jorge et al.
2007; Liu et al. 2007b; Tan et al. 2010b), no information is
available regarding the neuroprotection of specific brain
areas due to local synthesis of melatonin. In the current study,
we investigated whether neuroinflammation induces a shift
in melatonin synthesis from the pineal gland to other brain
areas. We also studied the putative functions of locally
produced melatonin. Specifically, we tested whether the
Immune-Pineal Axis theory can be applied in the brain and
whether it confers special protection to areas that can locally
produce melatonin following injury. Our findings reveal that
the acute neuroinflammatory response induced by intracer-
ebroventricular (icv) injection of lipopolysaccharide (LPS)
decreases nocturnal levels of circulating melatonin, while
inducing its local production in specific brain areas. More-
over, local melatonin synthesis correlated with lower neu-
ronal death, which offers new insight into why some brain
areas are more susceptible to neurodegeneration than others.
Material and methods
Animals
Male Wistar rats (2 months old, 180–200 g) were obtained
from the animal facility of the Department of Physiology
(IB-USP, Sa˜o Paulo, Brazil). They were subjected to a
12:12 h light/dark cycle (lights on at 07:00 hours = Zeit-
geber time zero or ZT 0) and received water and food
ad libitum. The animals were killed by decapitation or
transcardial perfusion with a fixative solution. Procedures
were approved by the IB-USP Ethical Committee (license
number 082/2008) and carried out in compliance with the
recommendations of the National Council on Experimental
Animal Control (CONCEA).
Drugs and reagents
Lipopolysaccharide (LPS, from E. coli serotype 0127:B8),
glycerol buffer, pyrrolidinedithiocarbamate (PDTC), lu-
zindole, trypsin, trypsin inhibitor, melatonin, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
DPX, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and the monoclonal anti-GFAP Cy3-con-
jugated (S9205), rabbit anti-AA-NAT (S0939) and anti-
rabbit FITC-conjugated IgG (F7512) antibodies were
obtained from Sigma-Aledrich Chemical (St. Louis, MO,
USA). Ascorbic acid and ethylenediaminetetraacetic acid
(EDTA) were purchased from Merck (Rio de Janeiro, RJ,
Brazil). 6-Diamidino-2-phenylindole (DAPI), was obtained
from Life Technologies (Carlsbad, CA, USA). The mouse
anti-NeuN monoclonal antibody was obtained from Milli-
pore Co. (Billerica, MA, USA), the mouse anti-ED1
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(ab31630) and goat anti-IBA1 (ab5076) antibodies were
purchased from Abcam (Cambridge, UK), and the donkey
anti-mouse Cy3-conjugated IgG (715165150) antibody was
purchased from Jackson ImmunoResearch (West Grove,
PA, USA). Fluoro-Jade B was obtained from Chemicon
International Inc. (Temecula, CA, USA). Dulbecco’s
modified Eagle’s medium (DMEM), fetal calf serum and
penicillin/streptomycin were obtained from GIBCO BRL
Products (Grand Island, NY, USA).
Surgical procedure
Rats were anesthetized using ketamine (100 mg/kg) and
xylazine (40 mg/kg, i.p.). A guide cannula (Plastics One,
Roanoke, VA, USA) was lowered via a stereotaxic arm to a
depth of 3.5 mm from the dura mater into the right lateral
ventricle (1.4 mm lateral and 0.4 mm posterior to the
bregma), permanently affixed to the skull using anchor
screws (Plastics One, Roanoke, VA, USA) and dental
acrylic (Jet Cla´ssico, SP, Brazil) and covered with a dummy
cannula (Plastics One, Roanoke, VA, USA). After surgery,
the animals were placed in a warm chamber to recover from
anesthesia before being placed back in their home cages and
maintained for 7–10 days prior to experimental procedures.
A total of 5 lL (1 lL/min) of LPS (3 lg/injection) or
saline was injected in the lateral ventricle through an infu-
sion probe (Plastics One, Roanoke, VA, USA) connected to
a Hamilton gastight syringe (Hamilton Co., Reno, NV,
USA) at ZT 6. After 12 h (at ZT 18), the animals were killed
by decapitation, and plasma or brain tissue samples were
collected to determine melatonin concentration and identify
serotonin derivatives. For immunohistochemical analysis,
the animals were anesthetized and transcardially perfused
(saline followed by 4 % paraformaldehyde) at ZT 18.
Inhibition of NF-jB activity and melatonin receptors was
achieved by injecting PDTC (100 lg/kg, i.p., at ZT 4) and
luzindole (10 lM, icv, at ZT 5 and ZT 12), respectively.
Pinealectomy was performed in rats anesthetized, as
described above, and placed in a stereotaxic apparatus.
Through an incision in the mid line of the skull, the skin
and muscles were pushed, the skull exposed and the bones
were drilled with a micromotor and a dental bur. A circular
piece of skull with approximately 4 mm of diameter made
in the lambda point allowed the visualization of the sagittal
and the transverse sinuses. The pineal gland, which is
located just below the confluence of the venous, was
removed. In the sham-operated animals, the same proce-
dure was performed except pineal extraction. The returning
of the disc-shaped bone closed the skull, and the scalp was
sutured with suture clips. The effectiveness of the pineal-
ectomy was evaluated by macroscopic post-mortem
examination and by determining the melatonin level in the
plasma at nighttime (Supplementary Fig. 1).
Tissue collection
For immunohistochemical analysis, animals were tran-
scardially perfused with 150 mL saline solution followed
by 400 mL of a cold (±4 C) 4 % formaldehyde fixative
solution at pH 9.5. The brains and pineal glands were
removed and post-fixed in the same fixative solution with
30 % sucrose for 4 h at 4 C. After fixation, the brains
and pineal glands were cryoprotected with 30 % sucrose
in 0.1 M phosphate buffer solution at pH 7.4 (PBS) and
frozen. Before freezing, the pineal glands were embedded
in Tissue Tek (Sakura, Torrance, CA, USA). The frozen
blocks were cut in serial sections (20 lm thick) on a
cryostat (Leica Microsystems Inc., Bannockburn, IL,
USA) and collected in PBS. Serial coronal brain sections
(30 lm thick) were cut with a cryomicrotome (Leica
Microsystems Inc., Bannockburn, IL, USA) and collected
in antifreeze solution (six series), one series per time was
used for immunohistochemistry or Fluoro-Jade B
staining.
Immunofluorescence
The expression patterns of AA-NAT in the pineal glands
and AA-NAT co-labeled with GFAP, NeuN, ED-1 or IBA1
were revealed using the indirect immunofluorescence
method on free-floating sections.
First, the sections were incubated in blocking solution
[1 % normal goat serum (NGS, Vector, Burlingame, CA,
USA), 0.3 % Triton X-100 in 0.1 M PBS, pH 7.4] for 1 h
at room temperature, followed by incubation with the pri-
mary antibodies diluted in the same solution (48 h at 4 C).
Next, the sections were rinsed with PBS and incubated with
secondary antibodies diluted in a similar solution for
90 min. Nuclei were stained with DAPI. After rinsing, the
brain sections were mounted on gelatin-coated slides and
covered with a cover glass, using glycerol buffer as a
mounting medium.
For double immunofluorescence, mouse monoclonal
anti-GFAP Cy3-conjugated (1:2,000), mouse anti-NeuN
(1:1,000), rabbit anti-AA-NAT (1:500), mouse anti-ED-1
(1:100) and goat anti-IBA1 (1:200) primary antibodies
were used. The concentrations of the antibodies were
chosen according to a concentration–response curve for
each antibody. Anti-rabbit FITC-conjugated IgG (1:200)
and donkey anti-mouse Cy3-conjugated IgG (1:200) sec-
ondary antibodies were used.
All procedures were repeated at least three times. Con-
trols were performed by omitting the primary antibodies
from the procedure and substituting normal serum from the
same species. Staining was completely abolished under
these conditions.
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Fluoro-Jade B staining
Cell death was detected by the Fluoro-Jade B method. The
sections mounted on 2 % gelatin-coated slides were air-
dried for at least 12 h. The slides were immersed in 1 %
sodium hydroxide in 80 % alcohol for 5 min followed by
2 min in 70 % alcohol and 2 min in distilled water. The
slides were then transferred to a solution of 0.06 % potas-
sium permanganate for 10 min, rinsed and immersed in a
staining solution prepared from a 0.01 % stock solution of
Fluoro-Jade B and added to 0.1 % acetic acid vehicle solu-
tion at a final dye concentration of 0.0004 %. After 20 min
in the staining solution, the slides were rinsed, placed on a
slide warmer, cleared by immersion in xylene and covers-
lipped with DPX. Nuclei of undamaged cells were stained
with DAPI and analyzed by epifluorescent microscopy.
Cerebellar granule cell culture
Animals (7–8 days old) were decapitated, and each cere-
bellum was isolated, washed, cut into small pieces and
incubated in 0.05 % trypsin dissolved in physiological
solution (120 mM NaCl, 5 mM KCl, 1.2 mM KH2PO4,
1.2 mM MgSO47H2O, 25 mM NaHCO3 and 13 mM glu-
cose, pH 7.4) for 40 min at 37 C. Afterward, a trypsin
inhibitor (0.06 %) was added to the solution, and the cells
were isolated by mechanical dispersion followed by centri-
fugation (300g, 5 min). Cells were seeded (5 9 105–107
cells/well, 13.4 g/L DMEM, 10 % SFB, 25 mM K?, 44 mM
NaHCO3, 50 U/mL penicillin and 50 lg/mL streptomycin)
and maintained at 37 C in a 5 % CO2 atmosphere for
7 days. The culture medium was replaced every 48 h. On day
7, the cell cultures were incubated with LPS (30 and 100 ng/
mL) or vehicle for 24 h. The medium was collected to
determine the melatonin content through an ELISA assay.
Cell viability assay—MTT method
Cell viability was assessed in cerebellar cell cultures
challenged with LPS (30 ng/mL, 24 h) in the presence or
absence of luzindole (100 nM, 24 h). MTT was added to
the wells at a final concentration of 5 mg/mL for 2 h. The
reduced crystals of MTT (formazan) were dissolved in
DMSO (30 min) and read at 540 nm (Molecular Devices
SpectraMax 250). Viability was expressed as the percent-
age of the absorbance measured in control cells.
Indoleamine determination
Levels of serotonin, NAS and 5-hydroxy-indoleacetic acid
(5-HIAA) in the pineal gland were determined by high-per-
formance liquid chromatography (HPLC) through electro-
chemical detection according to a previously described
methodology (Da Silveira et al. 2010). Briefly, the glands
were homogenized in ice-cold 0.1 M perchloric acid
(120 lL) containing 0.02 % EDTA and 0.02 % sodium
bisulfite. After centrifugation, 20 lL of the resulting super-
natant was injected into the chromatographic system (Waters,
Milford, MA, USA), which was isocratically operated. The
mobile phase for serotonin, 5-HIAA and NAS (0.1 M sodium
acetate, 0.1 M citric acid, 0.15 mM EDTA and 10 % meth-
anol, pH 3.7) flowed at a rate of 0.95 mL/min through a 5-mm
Resolve C 18 reversed-phase column (Waters, Milford, MA,
USA). The detector potential was adjusted to ? 0.90 V
versus an Ag/AgCl reference electrode.
The brain tissues were homogenized in ice-cold 25 mM
Tris–Hcl pH 7.4 (400 lL) containing 1 mM EDTA and
1 mM EGTA. Melatonin concentration in the plasma, tis-
sues and culture media was determined using an ELISA
method according to the manufacturer’s specifications (rat
melatonin ELISA kit, IBL, Germany).
Imaging and data analysis
Double-labeled sections were analyzed and photographed
using a confocal laser-scanning microscope (LSM 510,
Zeiss, Baden-Wurttemberg, Germany). HeNe 543/633,
argon (excitation 488 nm) and enterprise (excitation
364 nm) lasers were used for Cy3 (560 nm emission),
FITC (505 nm emission) and DAPI (435–485 nm emis-
sion) imaging, respectively. To assess possible co-locali-
zation, images in the red and green channels were captured.
Co-localization appeared yellow in the merged images of
confocal optical sections. The Fluoro-Jade B staining was
analyzed with a Nikon E-1000 epifluorescence photomi-
croscope (Melville, NY, USA) with a cool snap camera
(Pro-color, Media Cybernetics, Silver Spring, MA, USA).
The Fluoro-Jade B positive cells were counted in all the
sections of each series using Image-Pro Plus software
(Media Cybernetics Inc., Silver Spring, MD, USA).
The relative contents of AA-NAT and other cell markers
were quantified by measuring the optical density (OD) of
fluorescence intensities. For each experimental series, all
high-resolution z-stack images were acquired with identi-
cal settings. The relative intensities were measured from
the raw images using Image-Pro Plus software (Media
Cybernetics Inc., Silver Spring, MD, USA) under fixed
thresholds across all slides.
Statistical analysis
The data are presented as the mean ± standard error of the
mean. Differences between two or more groups were tested
using Student’s t test or ANOVA followed by the New-
man–Keuls test, respectively. Values of p \ 0.05 were
considered statistically significant.
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Fig. 1 LPS (icv) and melatonin
production by the pineal gland.
a Plasma melatonin levels 12 h
after the injection of vehicle
(n = 8) or LPS (3 lg, ZT 6, icv,
n = 9). b Representative
photomicrographs of AA-NAT
immunoreactivity in pineal
sections from vehicle- and LPS-




contents in the pineal glands of
vehicle- and LPS-treated rats
(n = 6). The data are expressed
as the mean ± SEM with
*p \ 0.05. Scale bar 500 lm
Fig. 2 LPS increased AA-NAT expression. a Representative confo-
cal photomicrographs of immunolabeled rat coronal sections of the
cortex, the hippocampus [containing the pyramidal cell layer (Str.
Pyr) and the stratum radiatum (Str. rad)] and the cerebellum
[containing the molecular (Mo), granular (Gr) and Purkinje cell (Pj)
layers]. Qualitative analysis of AA-NAT (green) expression in the
vehicle and LPS groups. The cell nuclei were stained with DAPI
(blue). Arrows indicate cells surrounding blood vessels. Scale bar
100 lm
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Results
LPS (icv) decreases melatonin synthesis in the pineal
gland
LPS (3 lg, icv, ZT6) significantly reduced the nocturnal
concentration of melatonin in the blood as well as the
immunoreactivity for AA-NAT in pineal sections from rats
killed 12 h later (ZT 18) (Fig. 1a, b). The content of the
melatonin precursor NAS, the first product generated by
AA-NAT activity, was also reduced. The level of 5-HIAA
was significantly increased while serotonin content was not
affected (Fig. 1c). These data suggest that a reduction in
the availability of AA-NAT, which converts serotonin into
NAS, impairs the pineal synthesis of melatonin, diverting
serotonin to the monoaminooxidase (MAO) route. This
change in pineal function translates into a reduction in the
nocturnal surge of melatonin in the plasma.
LPS alters AA-NAT expression in specific brain areas
Given that LPS induces the transcription of the Aanat gene
in macrophages through the activation of NF-jB (Muxel
et al. 2012) we evaluated whether the same inflammatory
agent also alters the expression of this enzyme in different
areas and cell types (neurons and glial cells) of the central
nervous system.
A general view of AA-NAT expression in the cortex,
hippocampus and cerebellum of rats treated with vehicle or
LPS suggests that LPS treatment leads to an increase in
AA-NAT staining in the cerebellum (Fig. 2). In the hip-
pocampus and cortex, AA-NAT-immunoreactive (ir) cells
changed in form after LPS treatment. In tissues from
treated animals astrocytes present star-shaped forms while
in control tissues the fluorescence was observed as dots and
the cells had no specific morphology, suggesting that the
cellular localization of AA-NAT-ir is modified by LPS
Fig. 3 LPS did not increase





of the cortex, hippocampus and
cerebellum of vehicle- and LPS-
treated animals, showing
immunoreactivity to AA-NAT
(green) and NeuN (red). AA-
NAT-ir cells (white arrowhead),
NeuN-ir cells (black
arrowhead) and the co-
localization of AA-NAT and
NeuN (yellow in merged
channels, arrow) in the vehicle
and LPS groups. Scale bar
100 lm. b Quantification of
immunohistochemical results
showing no increase in the
optical density of AA-NAT and
NeuN-ir co-localization in the
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(Fig. 2). In the cerebellum of LPS-treated rats AA-NAT-ir
increased in the molecular, granular and Purkinje cell
layers (Fig. 2).
To further determine which cells were expressing AA-
NAT, we performed double-staining for AA-NAT with
NeuN, GFAP, ED-1 and IBA1, which are markers for
neurons, astrocytes and two different stages of activated
microglia, respectively. In cortical and cerebellar sections,
AA-NAT and NeuN staining did not co-localize in treated
or untreated animals (Fig. 3). However, in the hippocam-
pus, some NeuN-positive cells co-expressed AA-NAT
(Fig. 3a). Interestingly, cerebellar Purkinje cells, which are
known to be non-reactive to NeuN (Mullen et al. 1992;
Wolf et al. 1996; Weyer and Schilling 2003), but can be
identified by their morphology, exhibited AA-NAT-ir. No
significant difference in the co-localization of AA-NAT-ir
with NeuN-ir was detected between vehicle- and LPS-
treated rats (Fig. 3b).
The results were quite different for glial cells. In the
cortex and hippocampus, LPS induced clear morphological
changes in astrocytes, which exhibited notable branch
elongation (Fig. 4a). In addition, AA-NAT-ir co-localized
with GFAP in both vehicle- and LPS-treated groups in all
analyzed brain areas. In the cerebellum, astrocytes were
positively stained for both GFAP and AA-NAT throughout
the molecular layer. LPS induced a significant increase in
the co-localization of AA-NAT-ir with GFAP-ir only in the
cerebellum (Fig. 4b). Although the image in Fig. 4b sug-
gests much higher levels of AA-NAT-ir in cortical GFAP-
ir cells, Student’s t testing revealed a probability of 8 %.
Two different stages of activation were detected in
microglia cells, and the expression of AA-NAT-ir varied






of the cortex, hippocampus and
cerebellum of vehicle- and LPS-
treated animals, showing the
immunoreactivity to AA-NAT
(green) and GFAP (red). AA-
NAT-ir cells (white arrowhead),
GFAP-ir cells (black
arrowhead) and the co-
localization of AA-NAT and
GFAP (see merged image,
arrow) in the vehicle and LPS




density of AA-NAT and GFAP-
ir co-localization in the
cerebellum (n = 4 animals per
group). *Significantly different
(p \ 0.05)
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according to the brain area studied. Immunoreactivity to
both ED-1 (Fig. 5) and IBA1 (Fig. 6) was significantly
higher in brain slices from LPS-treated animals. LPS
induced significant increase in the co-localization of AA-
NAT-ir with ED-1 in the cortex and the cerebellum
(Fig. 5b). IBA1-positive microglia cells, which are round
in shape, co-labeled with AA-NAT after LPS treatment in
all analyzed areas (Fig. 6a). The marked increase in AA-
NAT and IBA1 double-staining following LPS treatment in
the cortex, hippocampus and cerebellum was evident by
quantitative analysis (Fig. 6b).
LPS induces melatonin synthesis in the cerebellum
but not in the cortex or the hippocampus
To evaluate the functionality of AA-NAT expression in the
cortex, hippocampus and cerebellum, we measured the
amount of melatonin in vehicle- and LPS-treated animals
in the three areas. In addition, a group of animals was
pinealectomized prior to vehicle or LPS icv injection to
distinguish between melatonin originating from the plasma
(i.e., pineal-derived melatonin) and locally produced
melatonin.
LPS treatment had no effect on melatonin levels in the
cortex, but produced a significant reduction in the hippo-
campus. Conversely, a fourfold increase was detected in the
cerebellum of LPS-treated animals (Fig. 7a). In the pinea-
lectomized groups, melatonin content was significantly
reduced in the cortex and hippocampus of both vehicle- and
LPS-treated animals. In contrast, the LPS-induced increase
in melatonin production observed in the cerebellum was not
reversed by pinealectomy. In addition, pinealectomy alone
induced an increase in melatonin content specifically in the
cerebellum, which was further enhanced after LPS






of the cortex, hippocampus and
cerebellum of vehicle- and LPS-
treated animals, showing the
immunoreactivity to AA-NAT
(green) and ED1 (red).
Representative images of AA-
NAT-ir cells (white arrowhead),
ED1-ir cells (black arrowhead)
and the co-localization of AA-
NAT and ED1 (arrow) in the
LPS group. Scale bar 100 lm.
b Quantification of
immunohistochemical results,
showing that after LPS
treatment, AA-NAT co-
localized with ED1 in a small
number of cells in the cortex,
but more prominently in the
cerebellum (n = 4 animals per
group). *Significant different
(p \ 0.05)
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treatment, confirming that cerebellar cells synthesize mel-
atonin (Fig. 7a). These observations were further confirmed
by in vitro experiments in which LPS (30 or 100 ng/mL for
24 h) induced melatonin production in cultured cerebellar
cells in a dose-dependent manner (Fig. 7b).
It has previously been shown that AA-NAT gene
expression and thus melatonin synthesis in RAW246.7
macrophages are driven by the transcription factor NF-jB
(Muxel et al. 2012), which is classically activated follow-
ing LPS stimulus. Therefore, we evaluated whether NF-jB
also mediates melatonin synthesis in the cerebellum.
Indeed, inhibition of NF-jB binding to DNA by injection
of PDTC 2 h prior to LPS injection reversed the induction
of melatonin synthesis in the cerebellum (Fig. 7c).
In summary, LPS differentially affected cerebellar glial
cells relative to the hippocampal and cortical cells. The
significant increase in AA-NAT-ir results in the synthesis
of melatonin by the cerebellum.
Local LPS-induced melatonin synthesis protects
cerebellar neurons
Given that only the cerebellum exhibited local melatonin
production and that melatonin receptors are expressed in
cerebellar cells in mice (Imbesi et al. 2008), rats (Laudon
et al. 1998), pigs (Williams et al. 1999) and humans (Al-
Ghoul et al. 1998) we further investigated whether mela-
tonin produced in the cerebellum could play a protective
role mediated by melatonin receptors. Fluoro-Jade B
staining indicated that LPS induces neuronal death in the
cortex and hippocampus, but not in the cerebellum
(Fig. 8a, c). When animals were treated with luzindole
(50 lM, icv, ZT5 and ZT12), a competitive antagonist of
melatonin receptors, the cerebellum became susceptible to
LPS-induced neuronal death (Fig. 8b, c). This effect was
further confirmed in cultured cerebellar cells in which the
reduction in viability caused by LPS (100 ng/mL, 24 h)






of the cortex, hippocampus and
cerebellum of vehicle- and LPS-
treated animals, showing the
immunoreactivity to AA-NAT
(green) and IBA1 (red).
Representative images of AA-
NAT-ir cells (white arrowhead),
IBA1-ir cells (black arrowhead)
and the co-localization of AA-
NAT and IBA (arrow) in the
LPS group. Scale bar 100 lm.
b Quantification of
immunohistochemical results
showing clear increase in AA-
NAT and IBA1 co-localization
in all three brain areas in the
LPS group (n = 4 animals per
group). *Significantly different
(p \ 0.05)
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was potentiated in the presence of luzindole (100 nM,
24 h) (Fig. 8d). Therefore, our data suggest that the mel-
atonin produced in the cerebellum acts through its mem-
brane receptors to protect this area from LPS-induced
neurotoxicity.
Discussion
In this study, we show that inflammatory stimuli in the
CNS activate the immune-pineal axis in a manner similar
to systemic inflammation, leading to a switch between
pineal and extra-pineal production of melatonin. In addi-
tion, locally produced melatonin protects the cerebellum
from neuroinflammatory toxicity.
The most intriguing finding of this study is that LPS
induced the synthesis of melatonin only in the cerebellum.
In the cortex and hippocampus, LPS did not increase the
concentration of melatonin above those found in tissues
from control rats. After pinealectomy, the level of mela-
tonin in both structures was highly reduced either in LPS-
treated or control animals, indicating the importance of the
pineal gland as a source of melatonin for the cortex and
hippocampus. The content of melatonin in the cerebellum
was significantly higher in pinealectomized animals, cor-
roborating data obtained in rat liver (Venegas et al. 2012).
However, the level of melatonin in the cortex and hippo-
campus was highly reduced, indicating that in our experi-
mental conditions the cerebellum, but not the cortex and
hippocampus, exhibits a local production of melatonin.
This difference is unlikely to be due to the modulation of
AA-NAT expression because AA-NAT-ir was increased by
LPS (icv) treatment in cells stained with ED-1 both in the
cortex and in the cerebellum, and in all the areas when cells
were stained with IBA1. Therefore, the activation of the
inflammatory response in the brain by LPS leads to an
increase in AA-NAT-ir in all areas evaluated, as predicted
by the immune-pineal axis hypothesis, although only the
cerebellum produced melatonin.
Our analysis of AA-NAT expression in different cell
types revealed that LPS significantly increased its expres-
sion primarily in cerebellar glial cells. Contrasting respon-
ses of different brain areas were also observed in a study of
basal and LPS-induced expression of cytokines (Kipp et al.
2008), which also depends on the activation of glial cells.
Different glial phenotypes following brain infection can
lead to either detrimental or protective activity (Butovsky
et al. 2001, 2005). This dual effect is strictly dependent on
the area evaluated and drives the specific susceptibility of
different cell types to injury conditions (Kim et al. 2000;
Kipp et al. 2008; Espinosa-Oliva et al. 2011; Pintado et al.
2011). Although we cannot determine why, in our experi-
mental conditions, the cerebellum, but not the hippocampus
and cortex, is able to synthesize melatonin after pinealec-
tomy we could show the mechanism of action. PDTC,
which inhibits the binding of NF-jB dimers to jB regu-
lating elements in the DNA, blocks the synthesis of mela-
tonin by the cerebellum. It is well known that NF-jB can
mediate both neurodegenerative and neuroprotective
responses depending on the cell type and/or stimulus
(O’Neill and Kaltschmidt 1997; Rivest 2009). The data
reported here suggest that the induction of melatonin
Fig. 7 LPS-induced changes in melatonin content vary according to
the brain structures. a Melatonin levels in the cortex, hippocampus
and cerebellum of vehicle- and LPS-treated animals submitted or not
to pinealectomy (px).*LPS = vehicle, #pinealectomized (px) =
control, n = 9; p \ 0.05. b Melatonin content in cultured cerebellar
cells challenged with LPS (30 and 100 ng/mL) for 12 h.
*Significantly different from vehicle p \ 0.05; n = 4. c Melatonin
levels in the cerebellum of vehicle- and LPS-(3 lg/5 lL, icv, ZT 6;
gray bar) treated animals in the presence or absence of the blockage
of proteasome with PDTC (100 lg/kg, i.p., ZT 4) 2 h before LPS
administration (gray hachured bar). The data are expressed as the
mean ± SEM. Significantly different *p \ 0.05; n = 6–9
836 Brain Struct Funct (2015) 220:827–840
123
synthesis might comprise one of the downstream mecha-
nisms by which NF-jB induced protective responses, as
melatonin cytoprotective effects are well described (Galano
et al. 2011, 2013; Pandi-Perumal et al. 2012).
The ability of LPS to induce neuronal death was less
pronounced in the cerebellum when compared to the cortex
or the hippocampus. However, when melatonin receptors
were blocked, cerebellar neurons became susceptible to the
neurotoxic effects of LPS, evidencing the role of melatonin
G-protein coupled receptors in mediating its neuroprotec-
tive effect in an autocrine manner. Because the melatonin
detected in the hippocampus is derived from the pineal
gland, it is reasonable that the suppression of nocturnal
melatonin surge by pinealectomy induces neuronal loss in
the hippocampus, which is reversed by melatonin admin-
istration (De Butte and Pappas 2007). The fact that not all
brain areas react similarly to LPS is not surprising because
neurodegenerative disorders often occur in brain region-
specific patterns, suggesting differences in the activity and
reactivity of glial cells (Hald and Lotharius 2005; Williams
et al. 2007). In this context, the ability to produce melatonin
and to express melatonin receptors emerges as a relevant
factor that might distinguish between protective and detri-
mental neuroinflammatory responses of the glial cells.
Traditionally, the neuroprotective effects of melatonin
and its metabolites have been associated with antioxidant
effects (Galano et al. 2011, 2013). A number of different
mechanisms mediates this action, such as the direct inter-
action and scavenging of reactive species of oxygen and
nitrogen or by genomic effects, leading to increase in the
expression of antioxidant enzymes, or by preserving
mitochondrial function (De Butte and Pappas 2007; Rennie
et al. 2009; Cardinali et al. 2010; Fan and van Bel 2010;
Wang 2009; Hashimoto et al. 2012; Srinivasan et al. 2011;
Alonso-Alconada et al. 2012; Cary et al. 2012). Never-
theless, the involvement of melatonin G-protein coupled
receptors MT1 and MT2 in mediating melatonin protective
effects has also been previously described in studies of
sepsis, apoptosis and brain injury (Fink et al. 2013; Husson
et al. 2002; Radogna et al. 2007; Wang et al. 2013).
Fig. 8 LPS-induced melatonin synthesis protected cerebellar neu-
rons. a Neuronal degeneration was assessed through Fluoro-Jade B
staining (green) in coronal slices of the cortex, hippocampus and
cerebellum of LPS-treated rats (3 lg/5 lL, icv, ZT 6). Cell nuclei
were stained with DAPI (blue). Arrows indicate dead cells, while
open arrowheads indicate the nuclei of undamaged cells. Scale bar
100 lm. b Fluoro-jade B staining (green) of dead cells (arrow) in the
cerebellum of LPS-treated animals (3 lg/5 lL, icv, ZT6) and animals
injected with the melatonin receptor antagonist luzindole (10 lM, icv,
ZT 5 and ZT 12) prior to LPS treatment. The nuclei of undamaged
cells (arrowhead) were stained with DAPI (blue). Scale bar 20 lm.
c Number of Fluoro-jade B positive cells in all three brain areas
analyzed in the vehicle, LPS and LPS ? luzindole (LPS ? LUZ)
groups (n = 4 animals per group). d Cell viability assay on cultured
cerebellar cells challenged with LPS (30 ng/mL, 24 h) in the presence
or absence of luzindole (100 nM, 24 h). Significant different from
vehicle *(p \ 0.01) or from luzindole **(p \ 0.001). Significantly
different from vehicle and LPS #(p \ 0.001)
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The expression of both MT1 and MT2 melatonin
receptors has been demonstrated in mice (Imbesi et al.
2008), rat (Laudon et al. 1998), pig (Williams et al. 1999)
and human (Al-Ghoul et al. 1998). Recently, using a
transgenic mouse, the expression of MT1 melatonin
receptors was confirmed in Purkinje cells and in the
molecular and granular layers of the cerebellum (Adamah-
Biassi et al. 2013), corroborating previous data using
2-[125I]-iodomelatonin assay in rats (Laudon et al. 1998).
Moreover, cerebellar granule cells in culture also exhibit
functional melatonin receptors (Huan et al. 2001). One of
the first reported roles of melatonin receptors in the cere-
bellum refers to the maintenance of human equilibrium
(Fraschini et al. 1999). Recently melatonin MT2 receptors
were shown to stimulate the migration of rat cerebellar
granule cells mediated by delayed rectifier outward potas-
sium current (Liu et al. 2007a). Here, we show that mel-
atonin acts as an autacoid in the cerebellum, interacting
with its own receptors in the same area that it is synthe-
sized. Blocking melatonin receptors with luzindole (icv)
increased the neurotoxic effect of LPS. Although the
intracellular pathways triggered by the activation of mel-
atonin receptors in this condition still remain to be eluci-
dated, the overall protective effect of melatonin usually
involves its modulatory action on the innate immune
response, reducing the synthesis of pro-inflammatory
cytokines by lymphocytes (Lardone et al. 2010; Gupta and
Haldar 2013), and enhancing phagocytosis by macrophages
(Pires-Lapa et al. 2013).
In summary, here we show that the immune-pineal axis
is activated following a neuroinflammatory response in the
brain. The absence of pineal-derived melatonin may have
further consequences, not only for the organization of the
circadian system, but also for the susceptibility to neuro-
degenerative processes, especially because not all the brain
areas are able to produce melatonin. In this regard, the
ability to synthesize melatonin confers a special protection
to cerebellar cells. The understanding of where, when and
how melatonin is produced and acts in distinct brain areas
is of clinical relevance since it provides valuable clues to
guide the establishment of efficient protocols for the ther-
apeutic use of this hormone in neuroinflammatory diseases.
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